The market for the radiotherapy is increasing as the treatment is quick and easy. The treatment is more effective than chemotherapy and surgery. Though treatment has some side effects but the therapy is widely preferred by doctors. The cancerous cells get destroyed totally and does not show its presence in future. The time required is much less in contrast to the chemotherapy.
Request Sample Copy:
View Ray, recently announced that the company has showcased its next generation MRI-guided radiation therapy solution, MRIdian Linac, at ESTRO 36, the annual meeting of the European Society for Radiotherapy and Oncology, which was held on May 5-9, 2017 in Vienna, Austria. Isoray, company also has a new technique which into phase 3 of the clinical trials which will treat prostate cancer. The technique for the treatment is known as brachytherapy alone.
Varian, company has recently presented a new radiosurgery techniques for the optimal targeting of the multiple metastases. The metastases targeted are in the brain, spine, head & neck, and lung at the International Stereotactic Radiosurgery Society (ISRS) meeting in Montreux, Switzerland. Company has also announced that it has been selected through its distributor, Business Alignment, to supply and install a Varian ProBeam Compact single-room proton therapy system in the oncology center at King Chulalongkorn Memorial Hospital in Bangkok, Thailand. First patient treatments are expected to start in the second half of 2019.
Global Radiotherapy Market Players:
Some of the players are involved in manufacturing of the Radiotherapy those are, GE Healthcare(UK), Siemens (Germany), Varian(India), Cardinal Health(US), Nordion(CA), Isoray(US), View ray (US), Fuji Holdings(Japan), Philips Healthcare (US), Shimadzu Corporation (Japan), Hologic (US).
Philips Healthcare, is a global leader in health technology, has announced the launch of IntelliSpace Oncology, a new cloud-based oncology decision-support solution that offers seamless data integration across specialties and locations, data-driven decision making, and tools for proactive patient involvement. Recently company has opened its first innovation center in Russia. The center is Located at the Skolkovo Innovation Center in Moscow. The center will have a team of scientists developing the next generation of health technologies based on computer and data science, and artificial intelligence in healthcare.
The other companies also have wide presence in the home and as well as foreign countries. They also have product variety of the radiotherapy. The companies have constantly working on their R&D to innovate new techniques for the treatment of cancer. As the cancer is deadly disease which has high prevalence rate. The diagnosis is done in later stages the companies are trying to provide best equipment to treat disease in less time.
Report Details @
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312